calendar
7,925 catalysts · 5,627 phase readout · 2,292 8k filing · 252 earnings · 3 pdufa · 2 approval · 1 adcom
7,925 catalysts · 5,627 phase readout · 2,292 8k filing · 252 earnings · 3 pdufa · 2 approval · 1 adcom
Items: 2.02, 9.01
Items: 2.02
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 1.01, 3.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 5.03, 9.01
Items: 5.07
Items: 2.02, 9.01
Items: 5.02, 5.07, 9.01
Items: 5.02
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 1.01, 2.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 8.01, 9.01
Items: 8.01, 9.01
Items: 1.02
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 8.01
Items: 8.01, 9.01
Items: 8.01, 9.01
action date of January 4, 2027
action date of Jan. 21, 2027
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain
Sponsor: Beijing Sport University. Phase: NA. Conditions: Patellofemoral Pain